 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Thai AIDS patients protest GlaxoSmithKlein over drug patent
Bangkok, Aug 7, 2006 Hundreds of Thais with HIV protested outside the Bangkok office of drugmaker GlaxoSmithKlein, to demand that the British pharmaceutical firm drop its effort to patent a key AIDS drug in Thailand. The company introduced the drug Combid to Thailand four years ago, but the Government Pharmaceutical Organization (GPO) produces its own generic version at one-fifth the price, or about 40 dollars for one course of treatment. The drug combines existing medications into a single pill, which makes it easier for patients to comply with their treatment programs. The activists from the AIDS Access Foundation argue that the medication does not merit a patent because combining existing drugs does not constitute a new invention. They say Britain rejected a patent on similar grounds. The activists fear that if the patent is granted, Thailand will no longer be able to produce the generic version, which would threaten treatment for tens of thousands of people. "This will have disastrous consequences for the government's ambitious treatment program." said Achara Eksaengsri, deputy director for research and development of the GPO. Of the 600,000 Thais with HIV, about 80,000 are receiving treatment. Some 18,000 new cases were reported last year. Thailand's treatment program has been widely credited with slashing the number of deaths from AIDS by about 75 percent last year. Community Email This Article Comment On This Article Related Links Nuclear Space Technology at Space-Travel.com
AIDS, in quotes
Paris, Aug 7, 2006 Quotes illustrating the history of AIDS ahead of the 16th International AIDS Conference, running in Toronto, Canada, from Aug 13-18. |
|
|
| The content herein, unless otherwise known to be public domain, are Copyright 1995-2006 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA PortalReports are copyright European Space Agency. All NASA sourced material is public domain. Additionalcopyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |
